APA

Menon A. G., Kuppen P. J. K., van der Burg S. H., Offringa R., Bonnet M. C., Harinck B. I. J., Tollenaar R. A. E. M., Redeker A., Putter H., Moingeon P., Morreau H., Melief C. J. M. & van de Velde C. J. H. (20040226). Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. : Cancer gene therapy.

Chicago

Menon Anand G, Kuppen Peter J K, van der Burg Sjoerd H, Offringa Rienk, Bonnet Marie Claude, Harinck Bert I J, Tollenaar Rob A E M, Redeker Anke, Putter Hein, Moingeon Philippe, Morreau Hans, Melief Cornelis J M and van de Velde Cornelis J H. 20040226. Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. : Cancer gene therapy.

Harvard

Menon A. G., Kuppen P. J. K., van der Burg S. H., Offringa R., Bonnet M. C., Harinck B. I. J., Tollenaar R. A. E. M., Redeker A., Putter H., Moingeon P., Morreau H., Melief C. J. M. and van de Velde C. J. H. (20040226). Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. : Cancer gene therapy.

MLA

Menon Anand G, Kuppen Peter J K, van der Burg Sjoerd H, Offringa Rienk, Bonnet Marie Claude, Harinck Bert I J, Tollenaar Rob A E M, Redeker Anke, Putter Hein, Moingeon Philippe, Morreau Hans, Melief Cornelis J M and van de Velde Cornelis J H. Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. : Cancer gene therapy. 20040226.